Anew Labs
An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.
$290MFunding
ParticipantGV
Gaorong Ventures
Activity from announced rounds
All recorded activity
- Rounds participated in
- 4
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $515M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in all activityMoonwalk Biosciences
Moonwalk Biosciences is developing adipose-targeted siRNA medicines for obesity and cardiometabolic disease. Its lead programs are designed to alter fat-tissue pathways while limiting effects on other tissues, with the lead obesity candidate in IND-enabling development ahead of planned human testing in 2027.
$70MSeries B
ParticipantAxoft
Develops implantable Brain-Computer Interfaces (iBCIs) for neurological disorders
$55MSeries A
Role not disclosedPulnovo Medical
Develops interventional therapies for pulmonary hypertension and heart failure
$100MStrategic
Role not disclosed